Autologous bone marrow transplant in a patient with sickle cell disease and diffuse large B-cell lymphoma

Transplantation Proceedings

Volumn 35, Issue 8, 2003, Pages 3089-3092

  Onitilo, A A ^a   Lazarchick, J ^a   Brunson, C Y ^a   Frei Lahr, D ^a   Stuart, R K ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN S; IRON CHELATE; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CASE REPORT; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN TISSUE; IRON CHELATION; LARGE CELL LYMPHOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT; SICKLE CELL ANEMIA; SURVIVAL TIME; TRANSFUSION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 0347761549     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.10.085     Document Type: Article

References (22)

1. Herrick J.B. Peculiar elongation and sickle-shaped red corpuscle in a case of severe anemia. Arch Int Med. 6:1910;517.
2. Diggs L.W. Anatomic lesions in sickle cell disease. Abrahamson H.B.J.W.D. Sickle Cell Disease: Diagnosis, Management, Education and Research. 1973;189 C V Mosby, St. Louis.
3. Dacie J.V. The Haemolytic Anaemias: Congenital and Acquired. Part I-The Congenital Anaemias. 1960;Grune & Stratton, New York.
4. Steinberg M.H., Ballas S.K., Brunson C.Y., et al. Sickle cell anemia in septuagenarians. Blood. 86:1995;3997.
5. Wierenga K.J., Hambleton I.R., Lewis N.A. Survival estimates for patients with homozygous sickle-cell disease in Jamaica a clinic-based population study . Lancet. 357:2001;680.
6. Davies S.C., Oni L. Management of patients with sickle cell disease. BMJ. 315:1997;656.
7. Platt O.S., Brambilla D.J., Rosse W.E., et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 330:1994;1639.
8. Miller S.T., Sleeper L.A., Pegelow C.H., et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 342:2000;83.
9. Philip T., Guglielmi C., Hagenbeek A., et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med. 333:1995;1540.
10. Heim S.M.F. Cancer Cytogentics. Chromosomal and Molecular Genetic Aberrations of Tumor Cells. 2nd ed. 1995;Wiley-Liss. p 266.
11. Abrams D.I., Kaplan L.D., McGrath M.S., et al. AIDS-related benign lymphadenopathy and malignant lymphoma clinical aspects and virologic interactions . AIDS Res. 2:(Suppl I):1986;S131.
12. Besien K.V., Cabanillas F. Clinical manifestation, staging, and therapy of Hodgkin lymphoms. Hoffman R., Benz E.B. Jr, Shattil S.J., et al. Hematology: Basic Principles and Practice. 3rd ed. 2000;P1293-13391 Churchill Livingstone.
13. Couderc B., Dujols J.-P., Mokhtari F., Norkowski J.-L., et al. management of adult aggressive non-Hodgkin's lymphomas. Critical Reviews in Oncology/Hematology. 35:2000;33.
14. Beatty P.G., Mori M., Milford E. Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor. Transplantation. 60:1995;778.
15. Kodish E., Lantos J., Stocking C., et al. Bone marrow transplantation for sickle cell disease. A study of parents' decisions. N Engl J Med. 325:1991;1349.
16. Schmitz N., Bacigalupo A., Labopin M., et al. Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol. 95:1996;715.
17. Schmitz N., Beksac M., Hasenclever D., et al. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood. 100:2002;761.
18. Koshy M., Weiner S.J., Miller S.T., et al. Surgery and anesthesia in sickle cell disease. Cooperative study of sickle cell diseases. Blood. 86:1995;3676.
19. Brian K., Adler D.E., Salzman M.H., et al. Fatal sickle cell crisis after granulocyte colony-stimulating factor administration. Blood. 97:2001;3313.
20. Wei Aa.G.A. Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/+ thalassemia. Blood. 97:2001;3998.
21. Abboud M., Laver J., Blau C.A. Granulocytosis causing sickle-cell crisis. Lancet. 351:1998;959.
22. Miller S.T., Sleeper L.A., Pegelow C.H., et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 342:2000;83.